Epidermal growth factor receptors on cultured neoplastic human thyroid cells and effects of epidermal growth factor and thyroid-stimulating hormone on their growth.

Epidermal growth factor (EGF) receptors on primary-cultured human thyroid cells from 27 neoplasias (nine adenomas and 18 differentiated carcinomas) were analyzed and compared with those on the cultured nonneoplastic part of human thyroid cells. Total binding of 125I-EGF to the nonneoplastic part, adenoma, and carcinoma cells did not differ significantly. Scatchard analysis showed that the neoplastic human thyroid cells, like their adjacent nonneoplastic counterparts, consistently possessed EGF receptors with two components. In a paired study of five patients, the association constant of the carcinoma cells' high-affinity component (Ka1) was found to be significantly lower than that of adjacent nonneoplastic thyroid cells (P less than 0.05). Furthermore, a study of the cells from 18 carcinomas revealed that overall their Ka1s (4.15 +/- 0.82 x 10(9) M-1, mean +/- SEM) were significantly lower than those of adenoma cells (10.34 +/- 1.51 x 10(9) M-1, n = 9) and of nonneoplastic cells adjacent to them (8.32 +/- 0.84 x 10(9) M-1, n = 23). The difference in Ka1s for adenoma and nonneoplastic thyroid cells was not statistically significant. The number of receptor sites (Cmax) per cell was not significantly different in any of the three. Incorporation of [3H]thymidine (dThd) increased significantly in all kinds of thyroid cells examined following the addition of 10 nM EGF, and the paired study showed that the size of this increase was not significantly different in neoplastic and adjacent nonneoplastic cells. The addition of 300 microunits/ml of thyroid-stimulating hormone caused a significant increase in dThd incorporation by adenoma cells but not by carcinoma or nonneoplastic cells. Furthermore, combined treatment with EGF and thyroid-stimulating hormone additively promoted adenoma cell growth only. A close inverse relationship was observed between Ka1 and the stimulatory effect of EGF on the dThd uptake in both nonneoplastic thyroid cells and adenoma cells. Carcinoma cells also showed similar profiles, but Ka1 relative to dThd increases were much smaller than the other two.

[1]  Y. Yarden,et al.  Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. , 1987, Biochemistry.

[2]  Y. Yarden,et al.  Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation. , 1987, Biochemistry.

[3]  S. Cohen,et al.  Epidermal growth factor , 1972, The Journal of investigative dermatology.

[4]  U. Murthy,et al.  Regulation of kinase and intermolecular bonding in intact and truncated epidermal growth factor receptor. , 1986, The Journal of biological chemistry.

[5]  M. Melamed,et al.  Expression of epidermal growth factor receptor in human cultured cells and tissues: relationship to cell lineage and stage of differentiation. , 1986, Cancer research.

[6]  S. Furukawa,et al.  Development of a sensitive enzyme immunoassay for human epidermal growth factor (urogastrone). , 1986, Clinica chimica acta; international journal of clinical chemistry.

[7]  L. Ericson,et al.  Location of epidermal growth factor receptors on porcine thyroid follicle cells and receptor regulation by thyrotropin. , 1986, Endocrinology.

[8]  J. Dumont,et al.  Stimulation of cell proliferation and inhibition of differentiation expression by tumor-promoting phorbol esters in dog thyroid cells in primary culture. , 1986, Cancer research.

[9]  Q. Duh,et al.  Epidermal growth factor receptors in normal and neoplastic thyroid tissue. , 1985, Surgery.

[10]  K. Kasai,et al.  Specific Epidermal Growth Factor Receptors on Porcine and Human Thyroid Membranes , 1985, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[11]  M. Das,et al.  Intrapeptide autophosphorylation of the epidermal growth factor receptor: regulation of kinase catalytic function by receptor dimerization. , 1985, Biochemistry.

[12]  B. Westermark,et al.  Thyrotropin modulates EGF receptor function in porcine thyroid follicle cells , 1985, Molecular and Cellular Endocrinology.

[13]  L. Bachrach,et al.  The effects of growth factors and serum on DNA synthesis and differentiation in thyroid cells in culture , 1984, Molecular and Cellular Endocrinology.

[14]  G. Schultz,et al.  Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture. , 1984, Cancer research.

[15]  J. Wittliff,et al.  Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels. , 1984, Cancer research.

[16]  B. Ozanne,et al.  Human squamous cell lung cancers express increased epidermal growth factor receptors. , 1984, The Journal of clinical investigation.

[17]  H. Humphries,et al.  Interaction of epidermal growth factor with receptors on human and porcine thyroid membranes. , 1984, The Journal of endocrinology.

[18]  Jonathan A. Cooper,et al.  C-kinase phosphorylates the epidermal growth factor receptor and reduces its epidermal growth factor-stimulated tyrosine protein kinase activity. , 1984, The Journal of biological chemistry.

[19]  A. Ullrich,et al.  Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences , 1984, Nature.

[20]  T. Libermann,et al.  Expression of epidermal growth factor receptors in human brain tumors. , 1984, Cancer research.

[21]  S. Hakomori,et al.  Glycosphingolipids as tumor-associated and differentiation markers. , 1983, Journal of the National Cancer Institute.

[22]  B. Westermark,et al.  Epidermal growth factor modulates thyroid growth and function in culture. , 1983, Endocrinology.

[23]  R. Ross,et al.  Interactions between the receptors for platelet-derived growth factor and epidermal growth factor , 1983, The Journal of cell biology.

[24]  J. Schlessinger,et al.  Lateral diffusion of epidermal growth factor complexed to its surface receptors does not account for the thermal sensitivity of patch formation and endocytosis. , 1982, Biochemistry.

[25]  J. Konishi,et al.  Adenylate cyclase activity in thyroid tissue from patients with untreated Graves' disease. , 1980, The Journal of clinical endocrinology and metabolism.

[26]  H. Coon,et al.  Culture of hormone-dependent functional epithelial cells from rat thyroids. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[27]  G. Todaro,et al.  Biologically active phorbol esters specifically alter affinity of epidermal growth factor membrane receptors , 1979, Nature.

[28]  B. Westermark,et al.  Thyrotropin is not a growth factor for human thyroid cells in culture. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[29]  E. Rozengurt,et al.  Inhibition of epidermal growth factor binding to surface receptors by tumor promotors. , 1979, Biochemical and biophysical research communications.

[30]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .

[31]  G. Carpenter.  Binding assays for epidermal growth factor. , 1985, Methods in enzymology.

[32]  S. Hakomori,et al.  Tumor-associated carbohydrate antigens. , 1984, Annual review of immunology.